Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
about
The Role of Cyclo(His-Pro) in NeurodegenerationThe Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and SenescenceCentral Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic BrainMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsQuinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticityPrediction of G Protein-Coupled Receptors with SVM-Prot Features and Random ForestInflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Effects of a compound from the group of substituted thiadiazines with hypothermia inducing properties on brain metabolism in rats, a study in vivo and in vitro.Can an FDA-Approved Alzheimer's Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid.The prion protein regulates glutamate-mediated Ca2+ entry and mitochondrial Ca2+ accumulation in neurons.Brain Under Stress and Alzheimer's Disease.Ventricular fibrillation cardiac arrest produces a chronic striatal hyperdopaminergic state that is worsened by methylphenidate treatment.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.Electroacupuncture regulates the stress-injury-repair chain of events after cerebral ischemia/reperfusion injury.Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα.Neuroprotective and neurorestorative potential of xenon.Procyanidin B2 Protects Neurons from Oxidative, Nitrosative, and Excitotoxic Stress.Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1.Glutamate Toxicity to Differentiated Neuroblastoma N2a Cells Is Prevented by the Sesquiterpene Lactone Achillolide A and the Flavonoid 3,5,4'-Trihydroxy-6,7,3'-Trimethoxyflavone from Achillea fragrantissima.Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity.The role of rosemary extract in degeneration of hippocampal neurons induced by kainic acid in the rat: A behavioral and histochemical approach.Gestational exposure to inorganic arsenic (iAs3+) alters glutamate disposition in the mouse hippocampus and ionotropic glutamate receptor expression leading to memory impairment.A Cystine-Rich Whey Supplement (Immunocal®) Provides Neuroprotection from Diverse Oxidative Stress-Inducing Agents In Vitro by Preserving Cellular Glutathione.Mitochondrial Division Inhibitor 1 (mdivi-1) Protects Neurons against Excitotoxicity through the Modulation of Mitochondrial Function and Intracellular Ca2+ Signaling.Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model.Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila.Differential Modulation of GABAA and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma.Hippocampus Glutamate and N-Acetyl Aspartate Markers of Excitotoxic Neuronal Compromise in Posttraumatic Stress Disorder.The Impact of Synaptic Zn2+ Dynamics on Cognition and Its Decline.Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.Physical exercise induces structural alterations in the hippocampal astrocytes: exploring the role of BDNF-TrkB signaling.Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß.
P2860
Q26741190-FAC4F81D-5519-4A45-8C0F-F56B87742AAEQ26745558-07047C3D-8A55-4489-8B0B-4AE88D95CA11Q26749567-A682EC5B-CDC9-4003-A710-A2246905E603Q26768648-ED43FF6E-E16B-4C65-9BFC-C2B1067AC7EEQ28075692-55EC90E0-57DA-4FB6-B113-8B8A348A1FCAQ28821994-485BA97D-6824-4E7B-A615-6F891043A3BDQ28830857-880A240C-CE5A-4128-9BA3-D40610CA1807Q31141746-75284116-DC09-44CB-BDDD-E547CF375257Q33709279-00CCC8CB-6A4E-4B40-AD86-8B1FC642D264Q33874260-C42A25D2-7D64-411A-84C7-8917BE67C459Q38158391-205450F4-2BEC-4A51-B18D-D790C7B1B2ACQ38663343-E7AFEB98-19D6-40D8-8288-A2D2CA5C4A93Q38682032-2FC2BC5B-01F1-4E42-8349-D42AD1394AD4Q38683062-87F0DDEC-AF13-4D1C-9F9F-1BB789E0F780Q38690582-9A867806-00A5-4C22-B5D8-CC23507313E9Q38954648-8F8EDBAA-467D-490B-97B8-6F2E5ECA5AEFQ39177919-8989FDB1-F8FF-424A-8025-5CA775711E59Q39387480-AACDD88D-EA8F-405A-8F4F-0D2BC14A56CCQ41043755-A82A7CE8-5CB1-4CD0-B227-CBF906088D17Q42730558-C94D03F6-18CC-42B8-B99F-27765C5BA82BQ42837220-AAD3AD4C-5B42-47F5-9DE6-C0159B656992Q46287091-1E71101A-2A3B-4BB8-BAF9-1D6F84627095Q46307937-C13D42E2-3B3F-4F36-94B9-8832AB5E0105Q46385240-294D8E27-69C6-49C9-8B4B-E546BF6C0A08Q46784328-E0F0E6EC-D606-47CE-A0E4-319EFB77FCBBQ47100797-8FD095F6-72F8-4683-A6D9-C5BB4DA91FDFQ47260999-1DB7030F-D9FA-4A1B-B9FA-D3C3007F9384Q47316679-42A61AAF-FC39-414B-BB0E-14F91C23B855Q47698283-C1FC99B7-DE9A-4577-A681-CE190D5B42ABQ47769743-E9FF042A-0F7C-4CA2-BC7D-43944DB59593Q47819640-21F3EAE9-0002-4870-AB2E-56068A1144DFQ47827839-E71FCA7D-3D51-4EDD-82AE-0DC2088363D0Q47844754-3EA3B42A-D494-4491-863B-711EE24F798CQ47847250-1BB93A40-26AA-4737-A758-E428CB785125Q47868877-998D2B9D-E627-41EA-B1F6-E3AEBBBBA94CQ47969952-C3FB80BC-E86A-4DE1-8153-E2A7FB033A16Q48307478-29A6B27A-B4BC-4061-930D-0F45B92EFEF6Q48327595-6D42ACEF-8859-49BA-94D1-2B9076DE2B4BQ48328807-47667C20-148F-419D-89E2-1283D55ADE8CQ48475079-4B7F9018-A0CD-498D-9440-BDDB6EDE5FB2
P2860
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@ast
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@en
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@nl
type
label
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@ast
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@en
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@nl
prefLabel
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@ast
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@en
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@nl
P2860
P3181
P356
P1476
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
@en
P2093
Jan Lewerenz
Pamela Maher
P2860
P3181
P356
10.3389/FNINS.2015.00469
P407
P577
2015-01-01T00:00:00Z